http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Boston Scientific To Webcast Fourth Quarter 2015 Earnings Call On February 4
-
Boston Scientific To Participate In 2016 J.P. Morgan Healthcare Conference
-
LUMINA Data Demonstrate 70 Percent Greater Low Back Pain Relief with Boston Scientific Precision Spectra™ Spinal Cord Stimulator System
-
Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter
-
Boston Scientific To Participate In Oppenheimer 2015 Healthcare Conference
-
Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device
-
Boston Scientific Scores Perfect 100 on Human Rights Campaign's 2016 Corporate Equality Index
-
Boston Scientific To Participate In Piper Jaffray 2015 Healthcare Conference
-
Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
-
Boston Scientific To Participate In Canaccord Genuity 2015 Medical Technology And Diagnostics Forum
-
Boston Scientific To Participate In Stifel Healthcare Conference
-
Boston Scientific Announces Results For Third Quarter 2015
-
Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies
-
Boston Scientific Launches Online Competition For New Digital Health Technologies
-
Boston Scientific Announces Scheduled Presentations At TCT 2015
-
Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System
-
Boston Scientific To Webcast Third Quarter 2015 Earnings Call On October 28
-
Boston Scientific Launches The Captivator™ EMR Device To Treat Diseases Of The Upper GI Tract
-
Eluvia™ Drug-eluting Vascular Stent System Demonstrates 12-month Primary Patency Of 96.1 Percent
-
Boston Scientific Announces CE Mark for the Vercise™ Primary Cell Deep Brain Stimulation System
-
Boston Scientific To Participate In 2015 Morgan Stanley Global Healthcare Conference
-
Boston Scientific To Participate In The 2015 Wells Fargo Healthcare Conference
-
Boston Scientific Announces CE Mark For MRI Compatible Labeling For ICD And CRT-D Systems
-
Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System
-
Flex Pharma Reports Second Quarter 2015 Financial Results
-
Boston Scientific Closes Acquisition Of The American Medical Systems Male Urology Portfolio
-
Boston Scientific Announces Equity Investment And Sales Cooperation Agreement With Preventice Solutions
-
Boston Scientific Announces Results For Second Quarter 2015
-
Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology
-
Boston Scientific Elects Donna A. James To Board Of Directors
-
Boston Scientific Bronchial Thermoplasty Treatment Recognized By American College Of Allergy, Asthma And Immunology
-
Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23
-
Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction
-
New Data Demonstrate Greater Pain Relief With Boston Scientific Precision Spectra™ Spinal Cord Stimulator System
-
Boston Scientific Launches The Precision Novi™ Spinal Cord Stimulator System in Europe
-
Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference
-
Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates
-
New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years
-
Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015
-
Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day
-
Boston Scientific Collaborates With MedAxiom And TogetherMD To Bring Value Based Solutions To Healthcare Systems
-
Boston Scientific Announces Results for First Quarter 2015
-
New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months
-
Boston Scientific To Participate In The Bank Of America Merrill Lynch 2015 Healthcare Conference
-
Boston Scientific Announces Strategic Collaboration With Brainlab AG
-
Trading Radar for 4/28: Ford (F), Aetna (AET), Twitter (TWTR), GoPro (GPRO), Panera Bread (PNRA) Report
-
Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference
-
Long-Term Data Underscore Safety And Efficacy Of The Boston Scientific S-ICD™ System
-
Boston Scientific Enrolls First Patient In New Study Designed To Demonstrate The Effect Of The Vessix™ Renal Denervation System
-
Boston Scientific Signs Strategic Alliance With Frankenman Medical Equipment Company

